Professor Lyn Gilbert is an infectious disease physician and clinical microbiologist and has Master’s degree in Bioethics.
She is a senior researcher at the Marie Bashir Institute for Emerging Infections and Biosecurity and at Sydney Health Ethics (formerly Centre for Values, Ethics and the Law in Medicine) at the University of Sydney.
Until recently she was Director of the Centre for Infectious Diseases & Microbiology Laboratory Services and Director of Infection Prevention and Control for Western Sydney Local Health District, at Westmead Hospital.
Her main research interests are prevention, surveillance, control and ethics of communicable diseases of public health importance.
Currently, her research focuses particularly on the ethics and politics of:
- hospital infection prevention and control and antimicrobial resistance, including responsibilities of healthcare professionals and healthcare organisations
- one health approaches to prediction and management of emerging infectious diseases.
Research Leader of
- Community perspectives on distributing an initially limited supply of vaccines in the event of an influenza pandemic
- Evaluating video-reflexive methods to improve infection prevention and use of personal protective equipment in Australian hospitals
- Understanding stakeholder beliefs, attitudes and responses to COVID-19 infection prevention and control (IPC): a multimodal qualitative study
- Constructing an ethical framework for priority allocation of pandemic vaccines
- Education and training in infection prevention and control: Exploring support for national standards
- Priority allocation of pandemic influenza vaccines in Australia – Recommendations of 3 community juries
- Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment
- COVID‐19 in a Sydney nursing home: a case study and lessons learnt
- Hospital Infection Prevention and Control (IPC) and Antimicrobial Stewardship (AMS): Dual strategies to reduce antibiotic resistance (ABR) in hospitals
- Medical interns’ reflections on their training in use of personal protective equipment
- Trajectories of hospital infection control: Using non-representational theory to understand and improve infection prevention and control
- Living with COVID-19: Planning policy for the next stage
- SARS, MERS and COVID-19—new threats; old lessons
- Hospital infection control: old problem – evolving challenges
- One Health and zoonotic uncertainty in Singapore and Australia: Examining different regimes of precaution in outbreak decision-making
- Enablers of, and barriers to, optimal glove and mask use for routine care in the emergency department: an ethnographic study of Australian clinicians
- Advancing Planetary Health in Australia: focus on emerging infections and antimicrobial resistance
- Communicable disease surveillance ethics in the age of big data and new technology
- Perspectives of Australian policy-makers on the potential benefits and risks of technologically enhanced communicable disease surveillance – a modified Delphi survey
- Managing the risk of Hendra virus spillover in Australia using ecological approaches: A report on three community juries
- Public preferences for One Health approaches to emerging infectious diseases: A discrete choice experiment
- Clinician perceptions of respiratory infection risk; a rationale for research into mask use in routine practice
- To follow a rule? On frontline clinicians’ understandings and embodiments of hospital-acquired infection prevention and control rules
- Presentation: Keeping our hospitals safe from exotic infections
- Presentation: Talking with patients: Improving clinician-patient communication around healthcare-associated infections using video-reflexive methods